Previous Close | 76.83 |
1-Year Change | 12.74% |
6-Months Change | -3.56% |
3-Months Change | -21.49% |
Moving Avg (50d) | 104.955 |
Moving Avg (200d) | 85.768 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 5.36B |
Beta (3-Years) | 1.07 |
Revenue Growth (ttm) | 50.43% |
Net Profit Margin (ttm) | 8.63% |
Return On Assets (ttm) | 6.84% |
EPS (ttm) | 1.49 |
PE Ratio (ttm) | 51.56 |
Dividend Yield | % |
Asset Description: | Lantheus Holdings, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-20 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
84.721 | 82.127 | 80.398 | 77.805 | 73.482 | 69.16 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |